18-Methylaminocoronaridine

(−)-18-Methylaminocoronaridine (18-MAC) is a second generation synthetic derivative of ibogaine developed by the research team led by the pharmacologist Stanley D. Glick from the Albany Medical College and the chemist Martin E. Kuehne from the University of Vermont.^[1][2]

18-Methylaminocoronaridine

Identifiers
CAS Number	1807784-35-5 N[EPA]
PubChem CID	71308131
ChemSpider	24721797 Y
CompTox Dashboard (EPA)	DTXSID301046165
Chemical and physical data
Formula	C22H29N3O2
Molar mass	367.493 g·mol−1
3D model (JSmol)	Interactive image
SMILES c4cccc1c4[nH]c3c1CCN2CC(C5)CC3(C(=O)OC)C2C5CCNC
InChI InChI=1S/C22H29N3O2/c1-23-9-7-15-11-14-12-22(21(26)27-2)19-17(8-10-25(13-14)20(15)22)16-5-3-4-6-18(16)24-19/h3-6,14-15,20,23-24H,7-13H2,1-2H3/t14-,15+,20+,22-/m1/s1 Y Key:YKMOJVPLIUXEIP-SVBQBFEESA-N Y
(verify)

See also

• 2-Methoxyethyl-18-methoxycoronaridinate
• 18-Methoxycoronaridine
• Coronaridine
• Ibogaine
• Noribogaine
• Voacangine